| Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches S Ghosh, A Javia, S Shetty, D Bardoliwala, K Maiti, S Banerjee, ... Journal of Controlled Release 337, 27-58, 2021 | 68 | 2021 |
| Lipid-based oral formulation strategies for lipophilic drugs V Patel, R Lalani, D Bardoliwala, S Ghosh, A Misra Aaps Pharmscitech 19 (8), 3609-3630, 2018 | 58 | 2018 |
| Combinatorial nanocarriers against drug resistance in hematological cancers: opportunities and emerging strategies S Ghosh, R Lalani, V Patel, D Bardoliwala, K Maiti, S Banerjee, ... Journal of Controlled Release 296, 114-139, 2019 | 42 | 2019 |
| Polymer-drug conjugates: Design principles, emerging synthetic strategies and clinical overview A Javia, J Vanza, D Bardoliwala, S Ghosh, LA Misra, M Patel, H Thakkar International Journal of Pharmaceutics 623, 121863, 2022 | 32 | 2022 |
| Co-delivery of cisplatin and siRNA through hybrid nanocarrier platform for masking resistance to chemotherapy in lung cancer V Patel, R Lalani, I Vhora, D Bardoliwala, A Patel, S Ghosh, A Misra Drug Delivery and Translational Research 11, 2052-2071, 2021 | 26 | 2021 |
| Nanocarriers in effective pulmonary delivery of siRNA: current approaches and challenges D Bardoliwala, V Patel, A Javia, S Ghosh, A Patel, A Misra Therapeutic delivery 10 (5), 311-332, 2019 | 26 | 2019 |
| Systematic development and characterization of inhalable dry powder containing Polymeric Lipid Hybrid Nanocarriers co-loaded with ABCB1 shRNA and docetaxel using QbD approach D Bardoliwala, V Patel, A Misra, K Sawant Journal of Drug Delivery Science and Technology 66, 102903, 2021 | 11 | 2021 |
| Development of a Dry Powder for Inhalation of Nanoparticles Codelivering Cisplatin and ABCC3 siRNA in Lung Cancer V Patel, D Bardoliwala, R Lalani, S Patil, S Ghosh, A Javia, A Misra Therapeutic Delivery 12 (9), 651-670, 2021 | 9 | 2021 |
| Parenteral controlled and prolonged drug delivery systems: therapeutic needs and formulation strategies I Vhora, D Bardoliwala, SR Ranamalla, A Javia Novel Drug Delivery Technologies: Innovative Strategies for Drug Re …, 2019 | 7 | 2019 |
| Drug Delivery Transl V Patel, R Lalani, I Vhora, D Bardoliwala, A Patel, S Ghosh, A Misra Res 11, 2052-2071, 2021 | 6 | 2021 |
| Formulation and clinical perspectives of inhalation-based nanocarrier delivery: a new archetype in lung cancer treatment D Bardoliwala, A Javia, S Ghosh, A Misra, K Sawant Therapeutic Delivery 12 (5), 397-418, 2021 | 5 | 2021 |
| Applications of Polymers in Colon Drug Delivery D Bardoliwala, D Baradia, J Amrutiya, A Misra Applications of Polymers in Drug Delivery, 187-220, 2021 | 1 | 2021 |
| Co‑delivery of Active Ingredient and siRNA through hybrid nanocarrier platform for masking resistance to chemotherapy in lung cancer V Patel, R Lalani, I Vhora, D Bardoliwala, A Patel, S Ghosh, A Misra Drug Deliv. Trans. Res, 1-20, 2020 | 1 | 2020 |
| Ligands and Receptors for Targeted Delivery of Nanoparticles: Recent Updates and Challenges A Javia, D Bardoliwala, M Patel Drug Delivery with Targeted Nanoparticles, 97-130, 2021 | | 2021 |
| Development of a dry powder for inhalation of nanoparticles codelivering Active Ingredient and ABCC3 siRNA in lung cancer V Patel, D Bardoliwala, R Lalani, S Patil, S Ghosh, A Javia, A Misra | | 2021 |
| Development of Nanocarriers for Simultaneous Delivery of Drug and Gene Therapeutics in Treatment of Drug Resistant Lung Cancer DR Bardoliwala PQDT-Global, 2021 | | 2021 |
